Prohealth Research Center

Doral, Florida 33166-6613

1 studies enrolling now · 16 studies all time

What they study most

Atopic Dermatitis, Chronic Gout, Chronic Uncontrolled Gout, Covid19, Cytomegalovirus, Diabetic Foot Ulcer, Enteric Hyperoxaluria, Functional Constipation, Gout, Healthy Volunteers, Iron Deficiency Anemia, Irritable Bowel Syndrome With Constipation (IBS-C)

Studies at this site

• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
• A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age — Completed
• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
• NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers — Running, not enrolling
• A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) — Completed
• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants — Stopped early
• A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age — Completed
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout — Completed
• Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects — Stopped early
• A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed
• Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial — Status unconfirmed
• Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA — Completed
• Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation — Completed